Crewe Advisors’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,000
Closed -$8.87K 812
2025
Q1
$8.87K Hold
1,000
﹤0.01% 431
2024
Q4
$13.7K Hold
1,000
﹤0.01% 399
2024
Q3
$27.4K Hold
1,000
﹤0.01% 370
2024
Q2
$24.5K Hold
1,000
﹤0.01% 514
2024
Q1
$21.3K Buy
+1,000
New +$21.3K ﹤0.01% 482